We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples

By LabMedica International staff writers
Posted on 15 Dec 2023
Print article
Image: The self-heating microfluidic devices can help detect diseases without expensive lab equipment (Photo courtesy of MIT)
Image: The self-heating microfluidic devices can help detect diseases without expensive lab equipment (Photo courtesy of MIT)

Microfluidics, which are miniature devices that control the flow of liquids and facilitate chemical reactions, play a key role in disease detection from small samples of blood or other fluids. Commonly known examples include at-home Covid-19 test kits, which use basic microfluidic technology. However, more complex microfluidic applications often require chemical reactions at precise temperatures. Typically, these advanced devices are produced in clean rooms and include heating elements made of expensive materials like gold or platinum, making the manufacturing process costly and challenging to scale. Researchers have now made a breakthrough by employing 3D printing to build self-heating microfluidic devices, potentially paving the way for the creation of affordable and efficient tools that could detect various diseases.

Scientists at the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA) innovatively utilized multimaterial 3D printing to fabricate microfluidic devices with integrated heating elements. This development allows for precise temperature control of fluids moving through the device's microscopic channels. The method is highly customizable, enabling engineers to design microfluidics that heat fluids to specific temperatures or follow defined heating patterns in designated areas of the device. Remarkably, this cost-effective production method requires only about USD 2 worth of materials for each fully functional microfluidic device.

The dimensions of the device are comparable to a U.S. quarter, and its production is quick, taking only a few minutes. This advancement is particularly significant for remote or under-resourced areas in developing countries, where access to expensive laboratory equipment for diagnostic tests is often limited. Looking ahead, the researchers aim to incorporate magnets directly into the microfluidic devices. These embedded magnets could facilitate chemical reactions that require the sorting or aligning of particles. The researchers are also investigating alternative materials capable of achieving higher temperatures. This innovation in microfluidic technology represents a significant step towards more accessible and efficient diagnostic tools, especially in areas with limited resources.

“Clean rooms in particular, where you would usually make these devices, are incredibly expensive to build and to run,” said Luis Fernando Velásquez-García, a principal scientist in MIT’s Microsystems Technology Laboratories (MTL). “But we can make very capable self-heating microfluidic devices using additive manufacturing, and they can be made a lot faster and cheaper than with these traditional methods. This is really a way to democratize this technology.”

Related Links:
MIT

Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
New
Washer Disinfector
Tiva 8
New
Moxifloxacin Resistance Assay
Allplex MG & MoxiR Assay

Print article

Channels

Microbiology

view channel
Image: The breakthrough system offers a faster way to diagnose bloodborne infections (Photo courtesy of Melio)

Culture-Free Platform Rapidly Identifies Blood Stream Infections

Neonatal sepsis is a life-threatening condition that results from bloodstream infections in newborns under 28 days old. Due to their immature immune systems, newborns are especially vulnerable to infections.... Read more

Pathology

view channel
Image: The AI tool can search through data and histology images for much more precise information on cancer treatment effectiveness (Photo courtesy of Shutterstock)

AI Tool Analyzes 30K Data Points Per Medical Imaging Pixel in Cancer Search

A new artificial intelligence (AI)-powered tool can detect cell-level characteristics of cancer by analyzing data from very small tissue samples, some as tiny as 400 square micrometers, equivalent to the... Read more

Industry

view channel
Image: The game-changing immunoassay diagnostics platform delivers results from whole blood sample in 10 minutes (Photo courtesy of SpinChip)

bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics

bioMérieux (Marcy l’Étoile, France) has agreed to acquire SpinChip Diagnostics (Oslo, Norway), the developer of a game-changing immunoassay diagnostics platform. The small benchtop analyzer is well adapted... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.